Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States
- PMID: 35637010
- DOI: 10.1016/j.amjcard.2022.03.060
Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States
Abstract
Contemporary data on the national trends in pulmonary embolism (PE) admissions and outcomes are scarce. We aimed to analyze trends in mortality and different treatment methods in acute PE. We queried the Nationwide Readmissions Database (2016 to 2019) to identify hospitalizations with acute PE using the International Classification of Diseases, Tenth Revision, Clinical Modification codes. We described the national trends in admissions, in-hospital mortality, readmissions, and different treatment methods in acute PE. We identified 1,427,491 hospitalizations with acute PE, 2.4% of them (n = 34,446) were admissions with high-risk PE. The rate of in-hospital mortality in all PE hospitalizations was 6.5%, and it remained unchanged throughout the study period. However, the rate of in-hospital mortality in high-risk PE decreased from 48.1% in the first quarter of 2016 to 38.9% in the last quarter of 2019 (p-trend <0.001). The rate of urgent 30-day readmission was 15.2% in all PE admissions and 19.1% in high-risk PE admissions. In all PE admissions, catheter-directed interventions (CDI) were used more often (2.5%) than systemic thrombolysis (ST) (2.1%). However, in admissions with high-risk PE, ST remained the most frequently used method (ST vs CDI: 11.3% vs 6.6%). In conclusion, this study showed that the rate of in-hospital mortality in high-risk PE decreased from 2016 to 2019. ST was the most frequently used method for achieving pulmonary reperfusion in high-risk PE, whereas CDI was the most frequently used method in the entire PE cohort. In-hospital death and urgent readmissions rates remain significantly high in patients with high-risk PE.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures Dr. Sanjog Kalra is a consultant and Speakers’ bureau and/or Advisory Board participant for Boston Scientific, Cardiovascular Systems Inc, Translumina Therapeutics, Abiomed Inc., and Philips Healthcare. Dr. Wissam Jaber receives consultation fees and research grants from Inari Medical. All other authors have no conflicts of interest to declare.
Similar articles
-
Systemic thrombolysis increases hemorrhagic stroke risk without survival benefit compared with catheter-directed intervention for the treatment of acute pulmonary embolism.J Vasc Surg Venous Lymphat Disord. 2017 Mar;5(2):171-176.e1. doi: 10.1016/j.jvsv.2016.11.005. Epub 2017 Jan 16. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28214483 Free PMC article.
-
Trends and outcomes of lytic-based therapies for high-risk pulmonary embolism: A nationwide analysis.Vasc Med. 2024 Feb;29(1):26-35. doi: 10.1177/1358863X231211331. Epub 2023 Dec 12. Vasc Med. 2024. PMID: 38084862
-
Acute Pulmonary Embolism During Pregnancy and Puerperium: National Trends and In-Hospital Outcomes.Mayo Clin Proc. 2021 Aug;96(8):2102-2113. doi: 10.1016/j.mayocp.2021.01.015. Epub 2021 Jun 15. Mayo Clin Proc. 2021. PMID: 34144802
-
Surgical pulmonary embolectomy and catheter-based therapies for acute pulmonary embolism: A contemporary systematic review.J Thorac Cardiovasc Surg. 2018 Dec;156(6):2155-2167. doi: 10.1016/j.jtcvs.2018.05.085. Epub 2018 Jun 8. J Thorac Cardiovasc Surg. 2018. PMID: 30005883
-
Known Unknowns in the Contemporary Management of High-Risk Pulmonary Embolism: What Do the Guidelines Tell Us.Interv Cardiol Clin. 2023 Jul;12(3S):e33-e35. doi: 10.1016/j.iccl.2023.08.003. Epub 2023 Oct 11. Interv Cardiol Clin. 2023. PMID: 38964821 Review.
Cited by
-
Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study.Circ Cardiovasc Interv. 2023 Oct;16(10):e013406. doi: 10.1161/CIRCINTERVENTIONS.123.013406. Epub 2023 Oct 17. Circ Cardiovasc Interv. 2023. PMID: 37847768 Free PMC article.
-
ECMO in the Cardiac Catheterization Lab-Patient Selection Is Key.J Cardiovasc Dev Dis. 2024 Dec 31;12(1):12. doi: 10.3390/jcdd12010012. J Cardiovasc Dev Dis. 2024. PMID: 39852290 Free PMC article. Review.
-
Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial.Circulation. 2025 Feb 4;151(5):260-273. doi: 10.1161/CIRCULATIONAHA.124.072364. Epub 2024 Oct 29. Circulation. 2025. PMID: 39470698 Free PMC article. Clinical Trial.
-
A cross-sectional study of outcomes for patients undergoing mechanical thrombectomy for pulmonary embolism during 2018-2022: Insights from the PINC AI Healthcare Database.Health Sci Rep. 2024 Apr 21;7(4):e2031. doi: 10.1002/hsr2.2031. eCollection 2024 Apr. Health Sci Rep. 2024. PMID: 38650733 Free PMC article.
-
Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative.Circulation. 2024 Oct;150(14):1140-1150. doi: 10.1161/CIRCULATIONAHA.124.067482. Epub 2024 Sep 12. Circulation. 2024. PMID: 39263752 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical